Tuesday, September 3, 2019

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX: $DN.TO) (OTCQX: $VRNDF) (OTCQB: $GBLX) (TSX: $TGOD.TO) (OTC: $TGODF), (OTCQB: $SING)

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX: $DN.TO) (OTCQX: $VRNDF) (OTCQB: $GBLX) (TSX: $TGOD.TO) (OTC: $TGODF), (OTCQB: $SING)

Delta, Kelowna BC –September 3, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Read this in full at

Today's podcast overview/transcript

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

But first, The Assembly of First Nations (AFN) is convening its first ever National Cannabis Summit on September 4-5, 2019 in Vancouver British Columbia on the territory of the Musqueam, Squamish and Tsleil-Waututh Nations.  Hundreds of delegates will gather to engage on the latest information and research relating to First Nations and cannabis, including key issues in areas like jurisdiction over sales and regulation, health impacts, social development impacts and economic development.  
The Summit is taking place at the Westin Bayshore Hotel located at 1601 Bayshore Drive.
The federal government passed the Cannabis Act and related legislation in 2018 and legal cannabis is now a reality. However, there are many issues and questions involving First Nations and cannabis that have not been properly addressed. The AFN's first ever National Cannabis Summit will be one of the most comprehensive examinations of the issues and the path forward to date. Delegates attending the Cannabis Summit will have the opportunity to hear from a number of high-profile speakers on many topics addressing the gaps in cannabis legislation, economic opportunities and First Nations jurisdiction and governance.  The Summit will advance the dialogue around First Nations and cannabis, inclusive of all approaches and perspectives on cannabis legalization.
A full agenda is available on the AFN website at www.afn.ca

DELTA 9 CANNABIS INC. (TSX:DN.TO) (OTCQX: VRNDFannounced that on August 30, 2019 it received its renewal license from Health Canada for a term of three years. This license authorizes Delta 9 to cultivate, process and sell cannabis from its Winnipeg production facility. The Company also provided investors with an update on cannabis oils sales, cannabis pre-rolls sales, and new product development.

The Company, through its subsidiary, Delta 9 Bio-Tech Inc. has received its renewed Standard Cultivation and Standard Processing license for cannabis from Health Canada. The Company has fulfilled Health Canada's rigorous specifications, and successfully passed all inspections.

"Delta 9 employees have worked hard to meet the requirements within Health Canada's strictly regulated licensing environment. It speaks to the professionalism of our team that it has maintained the high standards of safety, quality and security in accordance with Health Canada's regulations for licensed producers," said John Arbuthnot, Chief Executive Officer of Delta 9.

The Company has also received approval from Health Canada for sales of cannabis oil products. The Company has already completed production of several initial batches of its "Odyssey" and "Oasis" lines of ingestible oils and will proceed with sales of these products in the medical and recreational use cannabis markets.

In June this year the Company launched its "Bliss" line of pre-rolled cannabis products, which consist of blended cannabis flower, rolled in a cigarette format, or "joint" for sale in the medical and recreational use cannabis markets. To date the Company has produced and sold over 75,000 cannabis pre-rolls.

"It is management's belief that these products will become an increasingly important component of the medical and recreational use cannabis markets in the future," said John Arbuthnot, Chief Executive Officer of Delta 9. "A continually expanding line of high-quality cannabis products is a major goal for the Company over this year and this is the first of what we hope are several milestones in our progress."

Delta 9 has also acquired an exclusive license in Canada to manufacture and sell products made with the patented technology of Nanosphere Health Sciences Inc. for the delivery of cannabinoids via nanoparticle technology. The two companies are in the process of developing the first product for Canada; an intraoral cannabis oil containing cannabinoid nanoparticles.

The NanoSphere delivery system for cannabis works by nano-encapsulating active ingredients in phospholipid membranes for transportation through the skin and mucosa into the bloodstream within minutes. Cannabis applications of the technology include transdermal viscous gels, intranasal products and intraoral products, all of which provide rapid results, precise dosages and high bioavailability. The NanoSphere delivery system of cannabis can eliminate the need for inhalation or ingestion of cannabis, offering users a potentially safer and more effective method of consumption.

GB Sciences, Inc. (OTCQB: GBLXtoday announced that it has received notification from the U.S. Drug Enforcement Agency (DEA) that prior to making any decisions on the pending applications, the DEA intends to distribute regulations that govern the program of growing marijuana for scientific research under DEA registration. GB Sciences is one of just 33 companies that applied to the DEA to become registered under the Controlled Substances Act (CSA) to grow marijuana in order to supply DEA-registered researchers in the United States. Last week, after a three-year delay and following pressure by Congress, patients and researchers, the DEA announced that it will move forward with creating revised regulations and with reviewing the applications.

"We are well-positioned to meet and exceed the DEA's criteria, and we intend to aggressively pursue federal licensure," said Dr. Andrea Small-Howard, Chief Science Officer and Director of GB Sciences. "The sophistication of our facilities, our team's deep scientific experience, and our groundbreaking cannabinoid therapies are unparalleled in the United States."

According to the letter from the DEA, it is looking to facilitate research, advance scientific understanding about the effects of marijuana, and potentially aid in the development of safe and effective drug products that may be approved for marketing by the Food and Drug Administration.

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF)announced that it has obtained approval from Health Canada, under the Cannabis Regulations, to expand operations into its new hybrid greenhouse located in Hamilton, Ontario. The 123,000 square foot state-of-the-art facility will serve to increase TGOD's premium organic cannabis production as it expands its sales in Canada.

TGOD's hybrid greenhouse is the fruit of years of research and development. From its cutting-edge climate control systems and water recapture systems to LED lighting, it combines the latest technologies with natural elements such as living soil and natural sunlight.  This organic growing facility has a much better environmental footprint and lower waste than traditional large-scale cannabis growing.

"We are thrilled to start using this purpose-built hybrid greenhouse as we ramp up our production of premium organic cannabis, an underserved segment of the market," commented Brian Athaide, CEO of TGOD.  "Our team pioneered the concept of growing organic cannabis at scale; this hybrid greenhouse has been artfully designed for organic cultivation, allowing us to reliably produce clean, safe and non irradiated cannabis."

The new facility is the third phase of TGOD's Hamilton site, measuring 166,000 square feet with an annual production capacity of 17,500 kgs of premium organic cannabis.  In line with its commitment to sustainability, TGOD aims to have the building LEED certified.
The Company is also seeking an eGMP certification for this facility in order to allow for global exports, as laws and regulations permit.

SinglePoint Inc. (OTCQB: SINGannounced that its subsidiary Direct Solar of America is planning along with GSX International Group and other larger corporations a first of its kind Hemp distribution center. Direct Solar of America will provide all energy solutions to production and distribution centers along with energy solutions to independent farmers in the co-op. Additionally, Direct Solar of America will facilitate the selling or assigning of ITCs between the farmers and centers or other third parties.

The opportunity to expand into the hemp market represents an opportunity to enter a market that is projected to be a multi-billion dollar market in just a few short years. An organization that can effectively combine the resources of small hemp farmers and establish centralized processing and distribution centers could corner the market on hemp processing for the foreseeable future. Combined with the current tax incentives offered through ITCs and Opportunity Zones, organizations that can access both will stand to reap the biggest profits.

The overall profit potential is enormous given the current solar tax incentives along with opportunity zone exemptions. The project is projected to be fully profitable within 3-4 growing cycles. Southern farmers will have multiple growing cycles during the year, while northern farmers will be traditionally limited to one per season. The real benefit of this structure is to take advantage of the tax exemptions currently available for opportunity zone development. It is this financial incentive that will make the project profitable within 24-36 months.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Subscribe to the new cannabis podcast series:

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Follow us on Social Media

Contact Investorideas.com


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories